Boston Scientific Corp
BSX- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000885725
In the last 90 days, Boston Scientific Corp insiders filed 5 open-market purchases and 0 sales; 1,486 institutions reported holding it in 13F filings for Q2 2026, worth $57.3B in total; Maverick Capital is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Boston Scientific Corp changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 882 | 11 | 866 | −5 |
| Shares | 1.30B | 171.0K | 1.31B | +10.0M (+0.8%) |
| Value | $48.6B | $6.38M | $50.9B | +$2.35B (+4.8%) |
11 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (82)
Institutions that held Boston Scientific Corp at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (87)
Institutions that held Boston Scientific Corp at the end of Q2 2022 and filed for Q3 2022 without it.
Not filed for Q3 2022 yet (11)
Institutions that held Boston Scientific Corp at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Brewin Dolphin Ltd | 48,285 | $1.80M |
| Exane Derivatives | 43,067 | $1.60M |
| Advisor Partners LLC | 36,065 | $1.34M |
| Dixon Hubard Feinour & Brown Inc | 19,920 | $742.0K |
| Coldstream Capital Management Inc | 12,901 | $481.0K |
| HighPoint Advisor Group LLC | 5,493 | $207.0K |
| Private Capital Group, LLC | 3,634 | $135.0K |
| Fieldpoint Private Securities, LLC | 1,061 | $40.0K |
| Brewin Dolphin Wealth Management Ltd | 300 | $11.0K |
| Quintet Private Bank (Europe) S.A. | 201 | $10.8K |
| Enterprise Trust & Investment Co | 67 | $2.00K |